T-Pharma Limited 09469761 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is Wholesale of pharmaceutical goods Digita Accounts Production Advanced 6.30.9574.0 true 09469761 2025-04-01 2026-03-31 09469761 2026-03-31 09469761 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 09469761 core:Non-currentFinancialInstruments core:AfterOneYear 2026-03-31 09469761 bus:Micro-entities 2025-04-01 2026-03-31 09469761 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 09469761 bus:FilletedAccounts 2025-04-01 2026-03-31 09469761 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 09469761 bus:RegisteredOffice 2025-04-01 2026-03-31 09469761 bus:Director1 2025-04-01 2026-03-31 09469761 bus:Director2 2025-04-01 2026-03-31 09469761 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 09469761 bus:Agent1 2025-04-01 2026-03-31 09469761 countries:EnglandWales 2025-04-01 2026-03-31 09469761 2024-04-01 2025-03-31 09469761 2025-03-31 09469761 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09469761 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 09469761

T-Pharma Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2026

T-Pharma Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 2

T-Pharma Limited

Company Information

Directors | Mr Anthony Mills Mrs Jennifer Mills

Registered office | The Coach House 56 West Avenue Walton Warrington WA4 6GH

Accountants | Azets Davidson Stant Limited Chartered Accountants2nd Floor Regis House 45 King William Street London EC4R 9AN

T-Pharma Limited

(Registration number: 09469761)
Balance Sheet as at 31 March 2026

| 2026 £ | 2025 £
Fixed assets | 51,776 | 60,901
Current assets | 421,493 | 492,349
Prepayments and accrued income | 1,954 | 1,686
Creditors: Amounts falling due within one year | (66,041) | (152,063)
Net current assets | 357,406 | 341,972
Total assets less current liabilities | 409,182 | 402,873
Creditors: Amounts falling due after more than one year | - | (5,011)
Accruals and deferred income | 143 | (4,312)
| 409,325 | 393,550
Capital and reserves | 409,325 | 393,550

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the Board on 22 July 2026 and signed on its behalf by:

......................................... Mr Anthony Mills Director

1 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2025 - 3).

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.